Life Science REIT PLC (LABS) — Cash Flow-to-Debt Ratio
Life Science REIT PLC (LABS) has a Cash Flow-to-Debt Ratio of 0.01x as of June 2025, meaning its operating cash flow of GBX958.00K could theoretically repay 0% of its total liabilities (GBX141.89 Million) in one year. Explore LABS strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Life Science REIT PLC Cash Flow-to-Debt Ratio (2021–2024)
Historical debt coverage capacity for Life Science REIT PLC across 4 annual periods. Also explore Life Science REIT PLC (LABS) total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Life Science REIT PLC (2021–2024)
Year-by-year debt coverage analysis for Life Science REIT PLC. For market capitalisation and broader financial context, see Life Science REIT PLC market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (GBX) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.09x | GBX12.92 Million | GBX138.42 Million | ▲ +55.6% |
| 2023 | 0.06x | GBX7.62 Million | GBX126.96 Million | ▲ +807.7% |
| 2022 | -0.01x | GBX-1.09 Million | GBX128.37 Million | ▼ -102.6% |
| 2021 | 0.33x | GBX3.54 Million | GBX10.82 Million | — |